Published Date：Jan. 2021
Industry：Pharma & Healthcare
Pages：102 Table Number：122
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Ivermectin Medication market in this environment. In terms of revenue, this research report indicated that the global Ivermectin Medication market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Ivermectin Medication industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The MERCK aims at producing XX Ivermectin Medication in 2020, with XX % production to take place in global market, Delta Pharma accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Ivermectin Medication Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Ivermectin Medication Market? MERCK Delta Pharma Galderma Arbor Pharmaceuticals Boehringer Ingelheim Edenbridge Pharmaceuticals ... Major Type of Ivermectin Medication Covered in XYZResearch report: Tablet Injection Lotion Cream Application Segments Covered in XYZResearch Market Oral External Use Application 3 For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Ivermectin Medication Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Tablet -Product Introduction and Major Manufacturers 1.1.2 Injection -Product Introduction and Major Manufacturers 1.1.3 Lotion -Product Introduction and Major Manufacturers 1.1.4 Cream -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Ivermectin Medication Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1 China Ivermectin Medication Market 3.1.1 Top Companies leading Ivermectin Medication Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 China Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2015-2026) 3.2 EU Ivermectin Medication Market 3.2.1 Top Companies leading Ivermectin Medication Development in EU (2015-2020) 3.2.2 Sales Value of Major Company in EU Market (2015-2020) 3.2.3 EU Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2015-2026) 3.3 USA Ivermectin Medication Market 3.3.1 Top Companies leading Ivermectin Medication Development in USA (2015-2020) 3.3.2 Sales Value of Major Company in USA Market (2015-2020) 3.3.3 USA Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2015-2026) 3.4 Japan Ivermectin Medication Market 3.4.1 Top Companies leading Ivermectin Medication Development in Japan (2015-2020) 3.4.2 Sales Value of Major Company in Japan Market (2015-2020) 3.4.3 Japan Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2015-2026) 3.5 India Ivermectin Medication Market 3.5.1 Top Companies leading Ivermectin Medication Development in India (2015-2020) 3.5.2 Sales Value of Major Company in India Market (2015-2020) 3.5.3 India Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2015-2026) 3.6 Southeast Asia Ivermectin Medication Market 3.6.1 Top Companies leading Ivermectin Medication Development in Southeast Asia (2015-2020) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020) 3.6.3 Southeast Asia Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2015-2026) 3.7 South America Ivermectin Medication Market 3.7.1 Top Companies leading Ivermectin Medication Development in South America (2015-2020) 3.7.2 Sales Value of Major Company in South America Market (2015-2020) 3.7.3 South America Ivermectin Medication Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2015-2026) 4 Value Chain (Impact of COVID-19) 4.1 Ivermectin Medication Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Ivermectin Medication Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2026) 5.1 Global Ivermectin Medication Sales and Growth Rate (2021-2026) 5.2 Global Ivermectin Medication Sales Value and Growth Rate (2021-2026) 6 Ivermectin Medication Competitive Analysis 6.1 MERCK 6.1.1 MERCK Company Profiles 6.1.2 MERCK Product Introduction 6.1.3 MERCK Ivermectin Medication Production, Revenue (2015-2020) 6.1.4 SWOT Analysis 6.2 Delta Pharma 6.2.1 Delta Pharma Company Profiles 6.2.2 Delta Pharma Product Introduction 6.2.3 Delta Pharma Ivermectin Medication Production, Revenue (2015-2020) 6.2.4 SWOT Analysis 6.3 Galderma 6.3.1 Galderma Company Profiles 6.3.2 Galderma Product Introduction 6.3.3 Galderma Ivermectin Medication Production, Revenue (2015-2020) 6.3.4 SWOT Analysis 6.4 Arbor Pharmaceuticals 6.4.1 Arbor Pharmaceuticals Company Profiles 6.4.2 Arbor Pharmaceuticals Product Introduction 6.4.3 Arbor Pharmaceuticals Ivermectin Medication Production, Revenue (2015-2020) 6.4.4 SWOT Analysis 6.5 Boehringer Ingelheim 6.5.1 Boehringer Ingelheim Company Profiles 6.5.2 Boehringer Ingelheim Product Introduction 6.5.3 Boehringer Ingelheim Ivermectin Medication Production, Revenue (2015-2020) 6.5.4 SWOT Analysis 6.6 Edenbridge Pharmaceuticals 6.6.1 Edenbridge Pharmaceuticals Company Profiles 6.6.2 Edenbridge Pharmaceuticals Product Introduction 6.6.3 Edenbridge Pharmaceuticals Ivermectin Medication Production, Revenue (2015-2020) 6.6.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020) Figure Global Ivermectin Medication Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2026) Table CAGR in Terms of Production of Each Type (2015-2026) Table CAGR in Terms of Production of Each Application (2015-2026) Table Global Ivermectin Medication Sales (K Unit) by Type (2015-2026) Figure Global Ivermectin Medication Sales (K Unit) and Growth Rate (2015-2026) Figure Global Ivermectin Medication Sales Market Share (%) by Type (2019 -2020) Table Global Ivermectin Medication Sales Value (Million USD) by Type (2015-2026) Figure Global Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2026) Figure Global Ivermectin Medication Sales Value Market Share (%) by Type (2019-2020) Table Global Ivermectin Medication Sales (K Unit) by Application (2015-2026) Table China Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table China Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table China Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure China Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table China Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table China Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table China Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure China Ivermectin Medication Sales (Unit) by Type (2015-2026) Table EU Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table EU Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table EU Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure EU Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table EU Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table EU Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table EU Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure EU Ivermectin Medication Sales (Unit) by Type (2015-2026) Table USA Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table USA Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table USA Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure USA Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table USA Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table USA Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table USA Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure USA Ivermectin Medication Sales (Unit) by Type (2015-2026) Table Japan Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table Japan Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table Japan Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure Japan Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table Japan Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table Japan Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table Japan Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure Japan Ivermectin Medication Sales (Unit) by Type (2015-2026) Table India Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table India Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table India Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure India Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table India Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table India Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table India Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure India Ivermectin Medication Sales (Unit) by Type (2015-2026) Table Southeast Asia Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table Southeast Asia Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table Southeast Asia Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure Southeast Asia Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table Southeast Asia Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table Southeast Asia Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure Southeast Asia Ivermectin Medication Sales (Unit) by Type (2015-2026) Table South America Ivermectin Medication Sales (K Unit) of Major Company (2015-2020) Table South America Ivermectin Medication Sales Market Share of Major Company (2015-2020) Table South America Ivermectin Medication Sales Value (Million USD) of Major Company (2015-2020) Figure South America Ivermectin Medication Sales Value (Million USD) and Growth Rate (2015-2020) Table South America Ivermectin Medication Sales Value Share of Major Company (2015-2020) Table South America Ivermectin Medication Price (USD/Unit), by Type (2019-2020) Table South America Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure South America Ivermectin Medication Sales (Unit) by Type (2015-2026) Figure Value Chain Structure of Ivermectin Medication Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Ivermectin Medication Figure Cost Structure of Ivermectin Medication in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2026) Table Regional Market Sales Share (2021-2026) Figure Global Ivermectin Medication Sales (Unit), Growth Rate & Market Share (2021-2026) Table Regional Market Sales Value (Million USD) (2021-2026) Table Regional Market Sales Value Share (2021-2026) Figure Global Ivermectin Medication Sales Value (Million USD), Growth Rate & Market Share (2021-2026) Table MERCK Profiles Table MERCK Ivermectin Medication Product Introduction Table MERCK Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure MERCK SWOT Analysis Table Delta Pharma Profiles Table Delta Pharma Ivermectin Medication Product Introduction Table Delta Pharma Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Delta Pharma SWOT Analysis Table Galderma Profiles Table Galderma Ivermectin Medication Product Introduction Table Galderma Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Galderma SWOT Analysis Table Arbor Pharmaceuticals Profiles Table Arbor Pharmaceuticals Ivermectin Medication Product Introduction Table Arbor Pharmaceuticals Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Arbor Pharmaceuticals SWOT Analysis Table Boehringer Ingelheim Profiles Table Boehringer Ingelheim Ivermectin Medication Product Introduction Table Boehringer Ingelheim Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020) Figure Boehringer Ingelheim SWOT Analysis Table Edenbridge Pharmaceuticals Profiles Table Edenbridge Pharmaceuticals Ivermectin Medication Product Introduction Table Edenbridge Pharmaceuticals Ivermectin Medication Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
